Yahoo Web Search

Search results

    • Merck to acquire EyeBio in potential $3B deal

      NJBIZ· 1 day ago

      On Wednesday morning, Rahway-headquartered Merck announced it will acquire EyeBio in a deal that has a potential value of $3 billion. The agreement will bring EyeBio into ...

    • Merck to buy eye drug developer for $1.3B

      Merck to buy eye drug developer for $1.3B

      BioPharma Dive via Yahoo Finance· 2 days ago

      An acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.